Skip to main content

Open

Japanese American Confinement Sites Grant Program

Request Ticket // Limit: 3 // Tickets Available: 1

J.J. Barrios (Public and Applied Humanities)
B. Carter (Center for Digital Humanities)

Limiting Language
Each applicant may submit up to 3 applications annually, for 3 separate projects, but each applicant can receive only 2 grants per fiscal year grant cycle.

Executive Summary
The Japanese American Confinement Sites (JACS) Grant Program provides financial assistance to organizations and entities working to preserve historic Japanese American confinement sites and their history, including: private nonprofit organizations; educational institutions; state, local, and tribal governments; and other public entities, for the preservation and interpretation of U.S. confinement sites where Japanese Americans were detained during World War II. 

Projects funded through the JACS Grant Program must benefit one or more historic Japanese American confinement sites. The term historic confinement sites are de-fined as the ten War Relocation Authority sites (Gila River, Granada, Heart Mountain, Jerome, Manzanar, Minidoka, Poston, Rohwer, Topaz, and Tule Lake), as well as other historically significant locations, as determined by the Secretary of the Interior, where Japanese Americans were detained during World War II. These sites are specifically identified in Confinement and Ethnicity: An Overview of World War II Japanese American Relocation Sites, published by the Department of the Interior, National Park Service, Western Archaeological and Conservation Center, in 1999. This document may be seen at https://www.nps.gov/parkhistory/online_books/anthropology74/.

For a full list of eligible project types and sites, please see the NOFO

Research Category
Funding Type
External Deadline
6/15/2026

Systematic Targeting of MicroPlastics (STOMP)

Notify Limited Submissions if you plan to submit a full proposal, include the topic area and lab you plan to submit on behalf of (you must have submitted a solution summary) // Limit: One full proposal (TA1 or TA2) per lab. 

Limiting Language 
Participation in multiple proposals – Only a small fraction of solution summaries are expected to be encouraged for full proposal submissions. At the solution summary stage, proposing entities may submit separate solution summaries for TA1 and TA2 as the prime. However, at the full proposal stage, proposing entities may only submit one full proposal (either TA1 or TA2) as the prime. Proposing entities may be part of multiple full proposal submissions as subcontractors. In this context a ‘proposing entity’ is an academic lab, small business, or unit of a large business. Different labs with different PIs from the same academic institution are considered separate proposing entities.

Introduction
A growing body of evidence suggests that micro- and nano-plastics (MNPs) harm human health. The Systematic Targeting Of MicroPlastics (STOMP) program seeks to better quantify MNPs in humans; understand the mechanisms of MNP deposition; and, ultimately, improve human health by developing means to limit uptake and remove MNPs from the body.

 

 

 

External Deadline
5/6/2026 (Solution Summaries for TA1 and TA2); 6/22/2026 (Full Proposals for TA1 and TA2)

2027 Macy Faculty Scholars Program

Request Ticket - must include approval messages from Department Head and Dean // Limit: 3 // Tickets Available: 2

The University of Arizona may submit a total of three nominations:

  • One from the College of Medicine - Tucson // Tickets Available: 0
    Y. Shirai (Family and Community Medicine, COM-T)
  • One from the College of Medicine - Phoenix // Tickets Available: 1
  • One from the College of Nursing // Tickets Available: 1


Eligibility:

  1. Be a benefits-eligible faculty member in a United States accredited nursing school, allopathic medical school, or osteopathic medical school. Candidates should have approximately three to eight years of faculty experience at the time of application.
  2. Be a doctorally prepared faculty member in good standing at the sponsoring school.
  3. Be nominated by the dean of the nursing or medical school. There can be only one nominee per nursing or medical school, and a nursing or medical school with a first-year Macy Faculty Scholar is precluded from nominating a candidate.
  4. Have an educational scholarship project with the appropriate institutional support.
  5. Have a faculty mentor who will advise the candidate on the candidate's educational project and career development.
  6. Have an institutional commitment for the protection of 50% of the candidate’s time.
  7. Be a citizen or permanent resident of the United States or its territories.

 

Program Overview

The Macy Faculty Scholars Program, now in its second decade, aims to identify and nurture promising early-career educators in medicine and nursing. The program will help develop the next generation of national leaders in medical and nursing education by identifying outstanding educators, physicians, nurses, and role models—individuals who represent the breadth of diversity seen in learners, patient populations, and health care settings around the country. By providing the Scholars with resources—especially protected time, mentorship, and a professional network of colleagues—the program aims to accelerate Scholars’ careers, to turn their teaching practice into scholarship, and to help them become impactful leaders locally, nationally, and beyond.

This is a career development award. The Foundation is interested in candidates for whom the program will have the maximum impact at this point in their career and who also have the greatest possibility for future impact at their home institutions and beyond. Macy Faculty Scholars will participate in the Macy Faculty Scholars Annual Meeting and will be part of the family of Macy Faculty Scholars for the remainder of their careers.

In order to develop the careers of educators who are future leaders, the Macy Faculty Scholars Program will provide salary support for each Scholar up to $100,000 per year, which will protect 50% of the Scholar’s time over two years. The Scholar will devote this time to a mentored educational scholarly project and other appropriate career development activities.

Funding Type
Internal Deadline
External Deadline
7/30/2026
Solicitation Type

Advancing Innovation and Collaboration Through C-SIPA

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Langauge
Applicants are only allowed to submit one proposal per organization. If more than one proposal is submitted from an organization, all proposals from that institution will be considered ineligible for funding under this funding opportunity.

Executive Summary
The U.S. Department of State’s Public Affairs Section (PAS) at U.S. Embassy Manama announces an open competition to support programs that advance high-tech research and innovation under the Comprehensive Strategic Integration and Prosperity Agreement (C-SIPA) between the United States, Bahrain, and the United Kingdom. C-SIPA strengthens trilateral cooperation under three pillars: 1) defense and security; 2) economic, commercial, and trade;
and 3) science, technology, and network security. This initiative contributes to broader U.S. efforts to reinforce national security, expand economic opportunity, and promote trusted technology partnerships.

The Embassy seeks proposals that foster collaboration among academic institutions and private sector partners with a focus on supporting economic and/or advanced technology cooperation under C-SIPA. This initiative aims to make America and its C-SIPA partners safer and more prosperous by promoting resilient, secure, and market-driven technology partnerships that uphold shared values and deliver measurable outcomes. Priority will be given to proposals that include direct collaboration with U.S. private sector partners and that engage all three C-SIPA countries.

If you have any questions about the grant application process in its entirety, please contact: ManamaPAO@state.gov. Please follow all instructions in the funding announcement. 

Research Category
Funding Type
External Deadline
7/6/2026
Solicitation Type

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Three RFAS - PAR-23-286, PAR-23-287, and/or PAR-23-288)

Request Ticket // Limit: 4* (see below) // Tickets Available: 4

Cancer Data Science // Limit: 1 // Tickets Available: 1

Cancer Control Science // Limit: 1 // Tickets Available: 1 

Molecular Precision/Cancer Prevention // Limit: 1 // Tickets Available: 1 

Other Cancer Research // Limit: 1 // Tickets Available: 1

Limiting Language
Each eligible institution (defined as having a unique UEI number or NIH IPF number) may submit up to a combined total of four applications (one in Cancer Data Science, one in Cancer Control Science, one in Molecular/Precision Cancer Prevention, and one in Other Cancer Research) to any companion NOFO or any combination of companion NOFOs (PAR-23-286, PAR-23-287, and/or PAR-23-288).

Scientific Areas

  • (A) Cancer Data Science: For the purposes of this K99/R00 award, cancer data science is defined as an interdisciplinary field of inquiry in which quantitative and analytical approaches, processes, and systems are both developed and used to extract knowledge and insights from increasingly large and/or complex sets of data. This includes cancer-focused data integration and visualization, systems biology, artificial intelligence, machine learning, informatics, genomics, precision oncology, and developing analytics for epidemiological or biostatistical studies.
  • (B) Cancer Control Science: For the purposes of this K99/R00 award, cancer control science is defined as basic and applied research in the behavioral, social, and population sciences to create or enhance interventions that, independently or in combination with biomedical approaches reduce cancer risk, incidence, morbidity, and mortality, and improve quality of life. This includes research in epidemiology, behavioral sciences, health services, surveillance, cancer survivorship, and healthcare policy.
  • (C) Molecular/Precision Cancer Prevention: For the purpose of this K99/R00 award, early translational research in cancer prevention is defined as basic research to understand mechanisms of cancer formation, development and progression of cancer precursors, and to translate basic biological knowledge into novel human interventions and human-centered adaption of current interventions with the potential to reduce cancer risk, incidence, and mortality, and improve quality of life. This includes but is not limited to research in molecular and systems biology, diagnostics, vaccine and drug development, pharmacology, and biomedical engineering.
  • (D) Other Cancer Research: For the purposes of this K99/R00 award, "Other Cancer Research" includes all scientific fields supported by the NCI that are not included in (A), (B) or (C). Applicants proposing research in (D) "Other Cancer Research" may apply only if it is reasonable to expect their candidates to transition to independence with an abbreviated period of mentored research training beyond their original doctoral degrees."
 


 

Funding Type
External Deadline
6/15/2026
Solicitation Type

2026 Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research

Awaiting RFA // Limit: 1 // Tickets Available: 1

Please note, the selection process is being run on an anticipated deadline based on prior cycles. We are monitoring the funder's website for details on the upcoming cycle and will update the limited submissions table once additional information on the 2026 cycle is available.

Limiting Language 
Each invited institution may submit a single application from a full-time faculty member. The candidate must be from the Colleges of Medicine (Tucson or Phoenix). 

Program Description

Full sponsor guidelines are linked here.

The Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research supports research in the prevention of coronary heart disease or circulatory failure and improving care for patients with these medical conditions. The program focuses on basic and translational scientific research. Clinical studies are currently ineligible. 

In accordance with Mr. Geneen’s directives, the program seeks to establish “…a more direct and personalized relationship with grant recipients than is normally possible in dealing with the diffuse and bureaucratic administrations through which large organizations are managed…and to support smaller institutions rather than major universities or medical complexes which have a demonstrated capacity to raise funds from the public generally.” Thus, eligible institutions represent mid-size institutions conducting relevant and innovative cardiovascular research. 

Each invited institution may only submit one application to the program which meets the eligibility requirements for the 2026 Grant Cycle. Applicants must be full-time faculty at an invited non-profit academic, medical, non-governmental or research institutions. United States citizenship is not required. Junior faculty are encouraged to apply. 

The Co-Trustees of the Harold S. Geneen Charitable Trust (Funder) have retained Health Resources in Action (HRiA - Administrator) to manage the administrative aspects of the Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research. Health Resources in Action (HRiA) is a non-profit organization that partners with individuals, organizations, and communities to transform the practices, policies, and systems that improve health and advance equity. 

Eligibility 
Each invited institution may submit a single application from a full-time faculty member. United States citizenship is not required. To encourage the support of junior faculty, applicants are ineligible if at the time of application, they have combined federal and nonfederal funding totaling $500,000 or more in direct costs during the first year of the Geneen Award. This figure refers to external funding only and not an applicant’s start-up package, other intramural support, or the Geneen Award itself. Applicants may hold a K Award or be in the R00 phase of a K99/R00 as long as those award amounts, combined with other funding, do not exceed these specified limits. 

Pending Federal and Non-Federal Support 
Applicants who have pending R01s or other large applications to the NIH and other agencies are encouraged to submit proposals to the Geneen Trust. Notification of funding after the application date will not impact eligibility for a Geneen Award. However, it is the responsibility of applicants to contact GeneenAwards@hria.org as soon as they are notified of any new funding. 

Funding Type
External Deadline
7/8/2026 (Anticipated)
Solicitation Type

FY 2026 English Access Scholarship Program

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Only one proposal will be considered by ECA from each applicant organization. In cases where more than one submission from an applicant appears in grants.gov, ECA will only consider the submission made closest in time to the NOFO deadline; that submission would constitute the one and only proposal ECA would review from that applicant.

Executive Summary
The English Access Scholarship Program (Access) leverages American English to build English language capacity with strategic audiences through in-person programming and exchanges in the United States. The program promotes economic self-reliance which strengthens American national security and economic prosperity. Access showcases U.S. educational excellence, demonstrates U.S. educational technology, and promotes opportunities for American business partnerships.

Research Category
Funding Type
External Deadline
5/1/2026
Solicitation Type